---
title: "Kala Bio tumbles after CEO resignation"
date: "2025-02-13 00:55:01"
summary: "** Shares of drug maker Kala Bio fall 34.6% to $7.12, set for record single-day fall** Company says its CEO Mark Iwicki has resigned, and President Todd Bazemore has been appointed as interim CEO** Iwicki has been with KALA for nearly a decade** Iwicki will continue as chair of the..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

\*\* Shares of drug maker Kala Bio fall 34.6% to $7.12, set for record single-day fall

\*\* Company says its CEO Mark Iwicki has resigned, and President Todd Bazemore has been appointed as interim CEO

\*\* Iwicki has been with KALA for nearly a decade

\*\* Iwicki will continue as chair of the board

\*\* KALA is set to report mid-stage trial data of its drug, KPI-012, in the second quarter of 2025, for the treatment of persistent corneal epithelial defects, a condition where injuries to the cornea, the clear front part of the eye, don't heal properly

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3P31GU:0-kala-bio-tumbles-after-ceo-resignation/)
